Structure of the human protein kinase ZAK in complex with vemurafenib.
The mixed lineage kinase ZAK is a key regulator of the MAPK pathway mediating cell survival and inflammatory response. ZAK is targeted by several clinically approved kinase inhibitors, and inhibition of ZAK has been reported to protect fromdoxorubicin-induced cardiomyopathy. On the other hand, unint...
| Hauptverfasser: | , , , , , , , , , , , , , |
|---|---|
| Format: | Journal article |
| Sprache: | English |
| Veröffentlicht: |
American Chemical Society
2016
|